[Invasive group A streptococcal infections in the Netherlands].

Invasieve groep A-streptokokkeninfecties in Nederland.

Journal

Nederlands tijdschrift voor geneeskunde
ISSN: 1876-8784
Titre abrégé: Ned Tijdschr Geneeskd
Pays: Netherlands
ID NLM: 0400770

Informations de publication

Date de publication:
16 03 2023
Historique:
entrez: 17 3 2023
pubmed: 18 3 2023
medline: 22 3 2023
Statut: epublish

Résumé

Group A streptococcal (GAS) infections are caused by the Gram-positive bacterium Streptococcus pyogenes. Infection can occur via droplet infection from the throat and via (in)direct contact with infected people. GAS can cause a wide variety of diseases, ranging from superficial skin infections, pharyngitis and scarlet fever, to serious invasive diseases such as puerperal sepsis, pneumonia, necrotising soft tissue infections (NSTI) (also known as necrotising fasciitis/myositis), meningitis and streptococcal toxic shock syndrome (STSS). In invasive GAS infections, the bacteria has penetrated into a sterile body compartment (such as the bloodstream, deep tissues, or the central nervous system). Invasive GAS infections are rare but serious, with high morbidity and mortality. Since March 2022, the National Institute for Public Health and the Environment (RIVM) reported a national increase in notifiable invasive GAS infections (NSTI, STSS and puerperal fever). Particularly NSTI has increased compared to the years before the SARS-CoV-2 pandemic. Remarkably, the proportion of children aged 0 to 5 years with invasive GAS-infections is higher in 2022 than in the previous years (12% compared to 4%). While seasonal peaks occur, the current elevation exceeds this variation. To promote early recognition and diagnosis of invasive GAS infections different clinical cases are presented.

Identifiants

pubmed: 36928399
pii:

Types de publication

English Abstract Journal Article

Langues

dut

Sous-ensembles de citation

IM

Auteurs

Natalie V S Vinkeles Melchers (NVS)

Wageningen University & Research, Health & Society Group, Wageningen.
Contact: Natalie V.S. Vinkeles Melchers (natalie.vinkelesmelchers@wur.nl).

Femke Nawijn (F)

UMC Utrecht, Utrecht. Afd. Chirurgie.

Lidewij W Rümke (LW)

UMC Utrecht, Utrecht. Afd. Medische Microbiologie.

Laura M L Dix (LML)

Erasmus MC - Sophia Kinderziekenhuis, Rotterdam: Afd. Medische Microbiologie.

Stefan M T Vestjens (SMT)

UMC Utrecht, Utrecht. Afd. Medische Microbiologie.

Falco Hietbrink (F)

UMC Utrecht, Utrecht. Afd. Chirurgie.

Raïssa Tjon-Kon-Fat (R)

GGD Zuid-Holland Zuid, Dienst Gezondheid & Jeugd ZHZ, Dordrecht.

Ellen Verspui-van der Eijk (E)

GGD Zuid-Holland Zuid, Dienst Gezondheid & Jeugd ZHZ, Dordrecht.

Brechje de Gier (B)

RIVM, Bilthoven.

Bart J M Vlaminckx (BJM)

St. Antonius Ziekenhuis, afd. Medische Microbiologie & Immunologie, Nieuwegein.

Caner Içli (C)

Albert Schweitzer ziekenhuis, Dordrecht. Afd. Orthopedie.

Marjolijn S W Quaak (MSW)

Erasmus MC - Sophia Kinderziekenhuis, Rotterdam: Afd. Kindergeneeskunde.

Elisabeth Inge G W Huijskens (EIGW)

Albert Schweitzer ziekenhuis, Dordrecht. Afd. Medische Microbiologie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH